2024-10-22 15:19:02,124 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:02,125 - INFO - Run 0:
[Scene: A dimly lit office at FiveThirtyEight, October 2, 2024]

Nate Silver: *shuffling through papers* "Well, Phil, another interesting case with the Mexico mpox prediction."

Philip Tetlock: "Indeed. When we last analyzed this on August 26, our models had it at 12.45%. The Swedish case was concerning, being the first Clade I case outside Africa."

Nate: "The WHO's PHEIC declaration definitely raised eyebrows. But Mexico's robust health surveillance system and limited direct travel connections with Central African outbreak zones worked in their favor."

Philip: "True. And while the Swedish case showed Clade I could reach Europe, Mexico's geographical position and travel patterns suggested a lower risk compared to countries with direct links to affected regions."

Nate: "The models accounted for Mexico's previous experience with Clade II mpox in 2022, which helped them maintain good surveillance, but ultimately..."

[They both look at the final report on their desk, confirming whether their prediction was correct]

2024-10-22 15:19:07,864 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:07,864 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:07,865 - INFO - Run 1:
[Scene: A dimly lit office at FiveThirtyEight headquarters, October 2, 2024]

Nate Silver: [looking at data screens] Phil, interesting how the Clade I mpox situation played out in Mexico.

Philip Tetlock: Indeed. Our models had it at 15.20%. The spread from Central Africa to Sweden in August was concerning, but the containment measures were remarkably effective.

Nate: The WHO's PHEIC declaration definitely heightened surveillance globally. Mexico's proximity to the US and robust health monitoring system made them particularly vigilant.

Philip: True, but the limited person-to-person transmission outside Africa and the quick isolation of the Swedish case worked in our favor. The historical containment of Clade I to just five Central African countries was a strong prior.

Nate: [nodding] The models captured that well. Even with increased global travel and the unprecedented spread to Sweden, the probability of Mexico confirming a case remained low.

Philip: Sometimes the unlikely outcome is just that - unlikely.

2024-10-22 15:19:07,865 - INFO - Run 1:
[Scene: A dimly lit office at FiveThirtyEight headquarters, October 2, 2024]

Nate Silver: [looking at data screens] Phil, interesting how the Clade I mpox situation played out in Mexico.

Philip Tetlock: Indeed. Our models had it at 15.20%. The spread from Central Africa to Sweden in August was concerning, but the containment measures were remarkably effective.

Nate: The WHO's PHEIC declaration definitely heightened surveillance globally. Mexico's proximity to the US and robust health monitoring system made them particularly vigilant.

Philip: True, but the limited person-to-person transmission outside Africa and the quick isolation of the Swedish case worked in our favor. The historical containment of Clade I to just five Central African countries was a strong prior.

Nate: [nodding] The models captured that well. Even with increased global travel and the unprecedented spread to Sweden, the probability of Mexico confirming a case remained low.

Philip: Sometimes the unlikely outcome is just that - unlikely.

2024-10-22 15:19:13,461 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:13,461 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:13,461 - INFO - Question: Will Mexico confirm Clade I mpox infections before October 1, 2024?
2024-10-22 15:19:13,462 - INFO - Run 2:
[Scene: A dimly lit office at FiveThirtyEight headquarters, October 2, 2024]

Nate Silver: [looking at data screens] Phil, interesting how the Clade I mpox situation played out in Mexico.

Philip Tetlock: Indeed. Our models had it at 15.20%. Despite the WHO's PHEIC declaration and that breakthrough case in Sweden back in August, the geographical spread remained relatively contained.

Nate: The models accounted for Mexico's robust health surveillance system and their experience with the 2022-23 mpox outbreak. But the limited spread of Clade I beyond Central Africa was the key factor.

Philip: Correct. Even with increased global vigilance after Sweden's case, the transmission patterns didn't suggest significant risk for Mexico. The containment measures in neighboring countries proved effective.

Nate: [nodding] The data from August showed concerning spread in Central Africa, but the geographical and travel patterns didn't point to Mexico as a likely next location.

Philip: Sometimes the most valuable forecasts are the ones that correctly predict what won't happen.

2024-10-22 15:19:13,462 - INFO - Run 2:
[Scene: A dimly lit office at FiveThirtyEight headquarters, October 2, 2024]

Nate Silver: [looking at data screens] Phil, interesting how the Clade I mpox situation played out in Mexico.

Philip Tetlock: Indeed. Our models had it at 15.20%. Despite the WHO's PHEIC declaration and that breakthrough case in Sweden back in August, the geographical spread remained relatively contained.

Nate: The models accounted for Mexico's robust health surveillance system and their experience with the 2022-23 mpox outbreak. But the limited spread of Clade I beyond Central Africa was the key factor.

Philip: Correct. Even with increased global vigilance after Sweden's case, the transmission patterns didn't suggest significant risk for Mexico. The containment measures in neighboring countries proved effective.

Nate: [nodding] The data from August showed concerning spread in Central Africa, but the geographical and travel patterns didn't point to Mexico as a likely next location.

Philip: Sometimes the most valuable forecasts are the ones that correctly predict what won't happen.

2024-10-22 15:19:13,462 - INFO - Run 2:
[Scene: A dimly lit office at FiveThirtyEight headquarters, October 2, 2024]

Nate Silver: [looking at data screens] Phil, interesting how the Clade I mpox situation played out in Mexico.

Philip Tetlock: Indeed. Our models had it at 15.20%. Despite the WHO's PHEIC declaration and that breakthrough case in Sweden back in August, the geographical spread remained relatively contained.

Nate: The models accounted for Mexico's robust health surveillance system and their experience with the 2022-23 mpox outbreak. But the limited spread of Clade I beyond Central Africa was the key factor.

Philip: Correct. Even with increased global vigilance after Sweden's case, the transmission patterns didn't suggest significant risk for Mexico. The containment measures in neighboring countries proved effective.

Nate: [nodding] The data from August showed concerning spread in Central Africa, but the geographical and travel patterns didn't point to Mexico as a likely next location.

Philip: Sometimes the most valuable forecasts are the ones that correctly predict what won't happen.

